Edwin Jonathan Tucker - Feb 13, 2025 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Chief Medical Officer
Signature
/s/ Herb Cross, as Attorney-in-Fact
Stock symbol
JSPR
Transactions as of
Feb 13, 2025
Transactions value $
$0
Form type
4
Date filed
2/18/2025, 05:29 PM
Previous filing
Jun 10, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JSPR Stock Option (right to buy) Award $0 +50K $0.00 50K Feb 13, 2025 Voting Common Stock 50K $6.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option shall vest on February 13, 2026, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.